Gottfries Clinic

Forskning

Referenser

  1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. American College of Rheumatology 1990 criteria for the classification of FMa. Report of the Multicenter Criteria Committe. Arthritis Rheum 1990;33:160–172.
  2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953-959.
  3. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, FMa, and temporomandibular disorder. Arch Intern Med 2000;160:221–227.
  4. Sivri A, Cindas A, Dincer F, Sivri B. Bowel dysfunction and irritable bowel syndrome in FMa patients. Clin Rheumatol. 1996;15(3):283-286.
  5. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications. Gastroenterology 2002;1122:1140-1156.
  6. Kennedy G, Spence V, Underwood C, Belch JJF. Increased neutrophil apptosis in chronic fatigue syndrome. J Clin Pathol. 2004;57:891-893.
  7. Redondo JR, Justo CM, Moraleda FV, Velayos YG, Puche JJ, Zubero JR, Hernandez TG, Ortells LC, Pareja MA. Long term efficacy in therapy in patients with FMa: a physical exercise-based program and a cognitive-behavioural approach. Arthritis Rheum. 2004 Apr 15;51(2):184-192.
  8. Zachrisson O. Fibromyalgi Chronic Fatigue syndrome. Aspects on biology, treatment and symptom evaluation. Doctoral thesis from Institute of Clinical Neuroscince, section of psychiatry 2002a. Göteborg University – Sweden
  9. Andersson M, Bagby JR, Dyrehag LE, Gottfries CG. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with FMa/chronic fatigue syndrome. European Journal of Pain 1998;2:133-142
  10. Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG. Treatment with staphylococcus toxoid in FMa/chronic fatigue syndrome – a randomised controlled trial. European Journal of Pain. 2002; 6:455-466.
  11. Zachrisson O, Colque-Navarro P, Gottfries C.G., Regland B, Möllby R. Immune Modulation with a Staphylococcal Preparation in FMa/Chronic Fatigue Syndrome: Relation Between Antibody Levels and Clinical Improvement. Eur J Clin Microbiol Infect Dis. 2004 Jan 20. 1570-1576.
  12. Gallinaro A.L., Ferldman D., Natour J. An evaluation of the association between fibromyalgia and repetitive strain injuries in metalworkers of an industry in Guarulhos, Brazil. Joint Bone Spine 2001;68:59-64.
  13. Al-Shatti T, Barr A E, Safadi F F, Amin M, Barbe M F. Increase in inflammatory cytokines in median nerves in a rat model of repetitive motion injury. J Neuroimmunology 2005;167:13-22.
  14. Maes M, Mihaylova I, Leunis JC.Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity. Neuro Endocrinol Lett. 2007 Dec 6;28(6) [Epub ahead of print] PMID: 18063934 [PubMed - as supplied by publisher]
  15. Maes M, Coucke F, Leunis JC. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome.